“An in silico evaluation of CDK Inhibitors targeting BCL2, TS and mTOR”, Asian J. Med. Biol. Res., vol. 7, no. 2, pp. 126–131, Jun. 2021, doi: 10.3329/ajmbr.v7i2.54991.